title: Overexpression of APP stimulates basal and constitutive exocytosis in PC12 cells.
abstract: The mechanisms that underlie the altered neurotransmitter system in Alzheimer's disease (AD) are not well understood. Amyloid precursor protein (APP) is a precursor protein for beta-amyloid, an important trigger protein in the pathogenesis of AD. Duplication of the APP gene as well as APP genes that contain certain mutations has been reported to be associated with familial AD (FAD), and a role of APP in neurotransmission has been suggested recently. This study examines the role of APP in exocytosis in PC12 cells using transfected human growth hormone (hGH) as a reporter for secretion. It was found that overexpression of APP or expression of the Swedish FAD mutation (APPsw) in PC12 cells significantly increased the basal secretion and constitutive secretion of hGH. Expression of an APP phosphorylation-deficient mutant decreased both basal and constitutive secretion relative to the APP wild-type, suggesting a role for APP-Thr668 phosphorylation in secretion in PC12 cells. Overexpression of X11alpha, a protein that stabilizes cellular APP, also increased the basal secretion of hGH but, contrary to APP, decreased the constitutive secretion of hGH, suggesting that basal and constitutive secretion is likely to proceed via distinct pathways and that the increase in the basal secretion of hGH may result from APP-X11alpha interaction. These results demonstrate an unknown role for APP in secretion, and suggest that elevated levels of APP or APP mutation in FAD brains contribute to the altered neurotransmitter pathology of AD through stimulation of basal and constitutive secretion.
authors.affiliation: Graduate Program in Neuroscience, Institute for Brain Science and Technology, Inje University, 633-146 Gaegeum 2-dong, Busanjin-gu, Busan 614-735, South Korea.
authors.forename: Hye-Won
authors.initials: HW
authors.lastname: Lee
authors.forename: Jeong Won
authors.initials: JW
authors.lastname: Park
authors.forename: Enkh-Undraa
authors.initials: EU
authors.lastname: Sandagsuren
authors.forename: Ki-Bae
authors.initials: KB
authors.lastname: Kim
authors.forename: Jin-Ju
authors.initials: JJ
authors.lastname: Yoo
authors.forename: Sul-Hee
authors.initials: SH
authors.lastname: Chung
mesh_terms: D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D015820:Cadherins / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005089:Exocytosis / Q000187:drug effects / Q000502:physiology*; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology*; D013006:Growth Hormone / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000378:metabolism; D016716:PC12 Cells / Q000187:drug effects; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014162:Transfection
chemical_list: D016564:Amyloid beta-Protein Precursor; C109650:Apba2 protein, rat; D015820:Cadherins; D002352:Carrier Proteins; D009419:Nerve Tissue Proteins; D011189:Potassium Chloride; D013006:Growth Hormone